Site Map (Alphabetical)

To see an ordinary site map click here

• Cardiac Function in Patients With Hereditary Hemochromatosis
  This study will examine the effect of iron buildup in the hearts of patients with hereditary hemochromatosis (HH), a genetic disease that causes the body to accumulate excess amounts of iron.
  
  
• Clinical Trials
  This is a list of some of the current Hemochromatosis clinical trials
  
  
• Details on the HFE Gene
  Details of the HFE Gene, The official name of this gene is hemochromatosis
  
  
• Disclaimer
  Disclaimer page for the Ironic Health Site
  
  
• Dr Whittington Bio
  Biography of Dr Whittington an authority on hemochromatosis
  
  
• Generic Information
  
  
• Hemochromatosis Articles
  At Ironic Health we are colating a range of artices regarding hemochromatosis
  
  
• Hemochromatosis Blog
  Blog for Ironic Health
  
  
• Hemochromatosis Gene
  Hemochromatosis Gene poster derived from the Human Genome Project
  
  
• Hemochromatosis in the Japanese
  Hemochromatosis in the Japanese is extremely rare; only 19 cases to date have been described
  
  
• Hemochromatosis Screening
  Hereditary Hemochromatosis fits the criteria set by the World Health Organization for population screening for a disease:
  
  
• Hemochromatosis Symptoms
  Probably the greatest difficulty in diagnosing early hemochromatosis is that it is nonspecific and symptoms are vague.
  
  
• Hemochromatosis Treatment
  The mainstay of hemochromatosis treatment is bloodletting also known as phlebotomy or venesection. This treatment is life long after diagnosis
  
  
• Hemochromatosis Videos
  
  
• Hemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
  In this project we plan to evaluate the effectiveness of erythrocytapheresis against phlebotomy, both regarding the impact on the reduction in hemochromatosis as well as reduction in patient 'burden'.
  
  
• Hereditary Hemochromatosis
  Hereditary Hemochromatosis (HH) is the most common genetic disorder of persons of northern European extraction.
  
  
• Hereditary Hemochromatosis-It can be Treated
  Hereditary Hemochromatosis (HH) is the most common genetic disorder of persons of northern European extraction. The mortality of HH can be reduced by early diagnosis and treatment by blood letting
  
  
• Iron Absorbtion by HFe Carriers
  Possible diet & genetic interaction was investigated by testing iron absorption of carriers for the genetic mutation for hemochromatosis,
  
  
• Iron Pills Can Harm
  Many people remember the old 'tired blood' advertising claims and still believe that iron pills will help if you suffer from chronic fatigue
  
  
• Iron: Too Much Can Harm You
  Several studies have shown that high blood levels of iron are associated with an increased risk of suffering heart attacks and cancers, particularly those of the esophagus and bladder
  
  
• Ironic Health
  Hereditary Hemochromatosis or too Much Iron Is Destroying The Health Of Millions Hereditary Hemochromatosis is the most common genetic disorder of persons of northern European extraction
  
  
• Miscellaneous Hemochromatosis Articles
  Other Hemochrmatosis articles not listed under more specific headings
  
  
• Recommended Resources
  
  
• Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
  Problems of neonatal compatibility between a mother and child of mothers with Hemochromatosis
  
  
• Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis
  Liver carcinoma is the main complication of cirrhosis. Treatment of symptomatic or large tumors is disappointing. Regular ultrasonographic screening of small curable tumors is currently recommended,
  
  
• Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)
  Compare transfusions and chelation therapy with hydroxyurea and phlebotomy therapy for the prevention of secondary stroke and management of iron overload in children with sickle cell anemia
  
  
• Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-Dependent Patients
  Systematical (retro- and prospective) investigation of long-term safety (toxicity assessment according to CTCAE v3.0) and efficacy of deferiprone given alone or in combination with desferrioxamine
  
  
• The impact of iron overload and its treatment on quality of life
  To assess the literature for the impact of iron overload and infusion Iron Chelation Therapy (ICT) on patients' quality of life (QoL), and the availability of QoL instruments for patients undergoing infusion ICT.
  
  
• Treatment for Hemochromatosis
  Articles on Treatment for Hemochromatosis
  
  
• Treatment of Hemochromatosis
  Evaluate the effectiveness of a test called MCV in guiding phlebotomy therapy in patients with hemochromatosis
  
  
• Type 1 Hemochromatosis Articles
  Articles on Hereditary Hemochromatosis or Type 1 Hemochromatosis
  
  
• Type 2 Hemochromatosis
  Hemochromatosis type 2 or juvenile hemochromatosis is different from the more common hemochromatosis type 1 or HFE related hemochromatosis primarily in that it is a more severe disease
  
  
• Type 2 Hemochromatosis Articles
  Articles on Juvenile Hemochromatosis or Type 2 Hemochromatosis
  
  
• Type 3 Hemochromatosis
  Hemochromatosis type 3 was the first non-HFE form of hemochromatosis for which a molecular diagnosis was made.
  
  
• Type 3 Hemochromatosis Articles
  Articles on Type 3 Hemochromatosis
  
  
• Type 4 Hemochromatosis
  Hemochromatosis type 4 or ferroportin disease is an autosomal dominant form of primary iron overload which occurs in adults
  
  
• Type 4 Hemochromatosis Articles
  Articles on Hemochromatosis type 4 or ferroportin disease Hemochromatosis
  
  
• What is Hemochromatosis
  Hemochromatosis (HE-mo-kro-ma-TOE-sis) is a disease in which too much iron builds up in your body. When this happens, the iron can poison the organs and lead to organ failure
  
  
• Who gets Hemochromatosis
  Hereditary hemochromatosis is the most common form of hemochromatosis. It is predominately a disorder of persons of northern European extraction.
  
  
• Privacy Statement
  
  
• Contact Us